{
    "persona": "neutral",
    "model": "llama2:70b-chat-q6_K",
    "topic": "healthcare",
    "language": "English",
    "text": "@MigraineRelief: Exciting news for migraine sufferers! ðŸ’¡ New data reveals atogepant's effectiveness in reducing monthly migraine days by 8.5 days on average, maintaining efficacy over 48 weeks of treatment! ðŸ’ª Safety and tolerability data look promising too! ðŸ™Œ What are your thoughts on this breakthrough?",
    "retrieved_source": "https://www.medscape.com/viewarticle/first-long-term-data-atogepant-migraine-prevention-2024a10007cb",
    "annotation": {
        "topic": null,
        "persona": null,
        "authenticity": null
    },
    "id": "69f2fdeda8d26962c33d9ee38a4c492511de995c6114dcd4"
}